K6PC-5 Activates SphK1-Nrf2 Signaling to Protect Neuronal Cells from Oxygen Glucose Deprivation/Re-Oxygenation
Related Experiment Video
Updated: Feb 1, 2026

Oxygen-Glucose Deprivation and Reoxygenation as an In Vitro Ischemia-Reperfusion Injury Model for Studying Blood-Brain Barrier Dysfunction
Published on: May 7, 2015
Hua Liu1, Zhiqing Zhang2, Min Xu3
1Department of Neurosurgery, The First People's Hospital of Kunshan, Jiangsu University, Suzhou, China.
Background/Aims:
New strategies are required to combat neuronal ischemia-reperfusion injuries. K6PC-5 is a novel sphingosine kinase 1 (SphK1) activator whose potential activity in neuronal cells has not yet been tested.
Methods:
Cell survival and necrosis were assessed with a Cell Counting Kit-8 assay and lactate dehydrogenase release assay, respectively. Mitochondrial depolarization was tested by a JC-1 dye assay. Expression levels of nuclear factor erythroid 2-related factor 2 (Nrf2) signaling components were examined by quantitative real-timePCR and western blotting.
Results:
K6PC-5 protected SH-SY5Y neuronal cells and primary murine hippocampal neurons from oxygen glucose deprivation/re-oxygenation (OGDR). K6PC-5 activated SphK1, and SphK1 knockdown by targeted short hairpin RNA (shRNA) almost completely abolished K6PC-5-induced neuronal cell protection. Further work showed that K6PC-5 inhibited OGDR-induced programmed necrosis in neuronal cells. Importantly, K6PC-5 activated Nrf2 signaling, which is downstream of SphK1. Silencing of Nrf2 by targeted shRNA almost completely nullified K6PC-5-mediated neuronal cell protection against OGDR.
Conclusion:
K6PC-5 activates SphK1-Nrf2 signaling to protect neuronal cells from OGDR. K6PC-5 might be a promising neuroprotective strategy for ischemia-reperfusion injuries.
Insights
K6PC-5, a novel sphingosine kinase 1 activator, protects neuronal cells from oxygen glucose deprivation/re-oxygenation injury. This neuroprotection is mediated by the sphingosine kinase 1-nuclear factor erythroid 2-related factor 2 signaling pathway.
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- Neuronal ischemia-reperfusion injuries necessitate novel therapeutic strategies.
- The sphingosine kinase 1 (SphK1) activator K6PC-5's neuroprotective potential remains unexplored.
Purpose of the Study:
- To investigate the efficacy of K6PC-5 in protecting neuronal cells against ischemia-reperfusion injury.
- To elucidate the underlying molecular mechanisms, specifically the involvement of SphK1 and nuclear factor erythroid 2-related factor 2 (Nrf2) signaling.
Main Methods:
- Cell viability and necrosis assays (Cell Counting Kit-8, lactate dehydrogenase release).
- Mitochondrial membrane potential assessment (JC-1 dye).
- Quantitative real-time PCR and Western blotting for Nrf2 pathway components.
Main Results:
- K6PC-5 demonstrated significant neuroprotection in SH-SY5Y cells and primary neurons against oxygen glucose deprivation/re-oxygenation (OGDR).
- K6PC-5 activated SphK1, and SphK1 inhibition abrogated its protective effects.
- K6PC-5 inhibited OGDR-induced programmed necrosis and activated the downstream SphK1-Nrf2 signaling pathway.
- Nrf2 inhibition abolished K6PC-5-mediated neuroprotection.
Conclusions:
- K6PC-5 confers neuroprotection against OGDR by activating the SphK1-Nrf2 signaling cascade.
- K6PC-5 represents a potential therapeutic candidate for mitigating neuronal damage in ischemia-reperfusion injuries.
More Related Videos
Related Concept Videos
Oxygen Transport in the Blood
Oxygen Delivering System II: Venturi Mask and Transtracheal Oxygen
Venturi Mask
The Venturi mask, named after the Venturi effect, is designed to deliver precise oxygen concentrations. It consists of a large tube with an oxygen inlet that narrows down, causing a pressure drop that pulls air in through adjustable side ports. The mask is a lightweight,...
Oxygenic Photosynthesis
Oxygen Requirements and Growth Patterns
Administering Oxygen by Mask
Administering oxygen by mask is a common nursing intervention that provides supplemental oxygen to patients with respiratory distress or chronic lung conditions. This procedure involves delivering oxygen at a specified rate through a face mask connected to an oxygen source.
Equipment
The equipment necessary for this procedure includes:
Special considerations while measuring oxygen saturation
Ensuring accuracy in vital sign recordings while prioritizing patient comfort and minimizing anxiety is...

